Georgia 2025-2026 Regular Session

Georgia Senate Bill SB220

Introduced
2/19/25  
Refer
2/20/25  
Report Pass
2/27/25  
Engrossed
3/6/25  
Report Pass
3/20/25  
Report Pass
2/10/26  

Caption

"Putting Georgia's Patients First Act"; enact

Impact

By establishing a clear regulatory framework, SB 220 is expected to affect state laws significantly, particularly around the criminal penalties associated with the possession and use of medical cannabis. The bill also addresses the registration process for patients who wish to access medical cannabis, creating a clearer pathway for them to obtain necessary legal authorizations. Additionally, it empowers the Georgia Access to Medical Cannabis Commission with increased oversight and regulatory authority, including the ability to purchase medical cannabis directly for patient use and establish a seed-to-sale tracking system to ensure compliance with legal standards.

Summary

Senate Bill 220 is a comprehensive piece of legislation aimed at modifying the existing legal framework surrounding the use of low THC oil in Georgia, effectively renaming it to medical cannabis. This bill proposes amendments to multiple chapters of the Official Code of Georgia Annotated, particularly focusing on the regulation of controlled substances, the responsibilities of the Georgia Access to Medical Cannabis Commission, and the registration system for patients. The legislation clarifies definitions and procedures related to the production, dispensing, and use of medical cannabis, enhancing the operational structure for its medical application in healthcare settings.

Sentiment

The sentiment surrounding SB 220 is generally positive among proponents who argue that clarifying the state's stance on medical cannabis will improve access for patients in need. Supporters from the medical community see this legislation as a step forward in recognizing the medical benefits of cannabis products, facilitating more appropriate treatments for those suffering from qualifying medical conditions. However, there are concerns about the implications for law enforcement and local regulations, with some opposing views highlighting the potential for misuse and the challenge of balancing regulation with patient access.

Contention

Notable points of contention have emerged primarily surrounding the proposed penalties for violations of the provisions set out in this bill. Critics argue that while the bill aims to facilitate access to medical cannabis, it also introduces notable penalties for those who may inadvertently violate regulations, which could lead to legal complications for patients and healthcare providers. Another area of concern is the prohibition against specific methods of ingestion, including smoking and vaporization for certain age groups, which some believe could limit therapeutic options available to patients.

Companion Bills

No companion bills found.

Previously Filed As

GA HB227

Putting Georgia's Patients First Act; enact

GA HB440

Providing Effective Access to Cannabis for Health (PEACH) Act; enact

GA HB1248

Georgia Cannabis Freedom and Integrity Act; enact

GA HB1252

Homes for Georgians First Act; enact

GA SB72

"Hope for Georgia Patients Act"; enact

GA HB555

Georgians First Residential Property Protection Act; enact

GA HB686

Georgia Sports Betting Act; enact

GA HB1480

Georgia Medicare for All Act; enact

GA SB395

Department of Public Health; eligible for the Low THC Oil Patient Registry; require a physician to submit certain information to the Georgia Composite Medical Board

GA SB254

"Georgia Hemp Farming Act,"; delta-9-THC in consumable hemp products; provide milligram limits

Similar Bills

No similar bills found.